HUTCHMED (China) Limited

HUTCHMED (China) Limitedverified

HCM

Price:

$14.3

Market Cap:

$2.51B

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract ca...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-03-16

Stock Exchange

NASDAQ

Ticker

HCM

The PE Ratio as of December 2024 (TTM) for HUTCHMED (China) Limited (HCM) is -57.20

According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current PE Ratio is -57.20. This represents a change of -418.71% compared to the average of 17.95 of the last 4 quarters.

HUTCHMED (China) Limited (HCM) Historical PE Ratio (quarterly & annually)

How has HCM PE Ratio performed in the past?

The mean historical PE Ratio of HUTCHMED (China) Limited over the last ten years is 137.76. The current -57.20 PE Ratio has changed -4252.23% with respect to the historical average. Over the past ten years (40 quarters), HCM's PE Ratio was at its highest in in the March 2016 quarter at 4.26K. The PE Ratio was at its lowest in in the March 2018 quarter at -108.67.

Quarterly (TTM)
Annual

Average

137.76

Median

-15.77

Minimum

-178.09

Maximum

760.25

HUTCHMED (China) Limited (HCM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of HUTCHMED (China) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 11.13%

Maximum Annual PE Ratio = 760.25

Minimum Annual Increase = -577.02%

Minimum Annual PE Ratio = -178.09

Quarterly (TTM)
Annual
YearPE RatioChange
202330.27-577.02%
2022-6.35-74.82%
2021-25.20-9.64%
2020-27.89-21.82%
2019-35.68-47.81%
2018-68.35-61.62%
2017-178.09-144.88%
2016396.80-25.39%
2015531.81-30.05%
2014760.2511.13%

HUTCHMED (China) Limited (HCM) Average PE Ratio

How has HCM PE Ratio performed in the past?

The current PE Ratio of HUTCHMED (China) Limited (HCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-0.43

5-year avg

-12.97

10-year avg

137.76

HUTCHMED (China) Limited (HCM) PE Ratio vs. Peers

How is HCM’s PE Ratio compared to its peers?

HUTCHMED (China) Limited’s PE Ratio is less than Eagle Pharmaceuticals, Inc. (0.19), greater than ANI Pharmaceuticals, Inc. (-148.20), less than Phibro Animal Health Corporation (50.36), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Prestige Consumer Healthcare Inc. (18.99), less than Pacira BioSciences, Inc. (-9.90), less than Collegium Pharmaceutical, Inc. (10.58), less than Procaps Group S.A. (7.23), less than Silver Spike Investment Corp. (0), less than Alkermes plc (14.53), greater than Intra-Cellular Therapies, Inc. (-104.38), less than Ironwood Pharmaceuticals, Inc. (29.47), less than Regencell Bioscience Holdings Limited (-13.79),

Build a custom stock screener for HUTCHMED (China) Limited (HCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HUTCHMED (China) Limited (HCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is HUTCHMED (China) Limited's PE Ratio?

How is the PE Ratio calculated for HUTCHMED (China) Limited (HCM)?

What is the highest PE Ratio for HUTCHMED (China) Limited (HCM)?

What is the 3-year average PE Ratio for HUTCHMED (China) Limited (HCM)?

What is the 5-year average PE Ratio for HUTCHMED (China) Limited (HCM)?

How does the current PE Ratio for HUTCHMED (China) Limited (HCM) compare to its historical average?